PortfoliosLab logoPortfoliosLab logo

SHSAX's Sharpe Ratio of 1.27 indicates that for each unit of volatility, it generates 1.27 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jun 24, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets. For how to read this number and when it can mislead, see Sharpe Ratio Explained.

SHSAX Sharpe Ratio Rank


SHSAX Sharpe Ratio Rank: 23.023
Below Average

SHSAX ranks above 23.0% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating below-average returns relative to volatility. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with low total volatility → Higher rank
  • High volatility (both upside and downside) → Lower rank
  • Consistent returns → Higher rank than volatile returns of same magnitude
  • Sharp drawdowns increase volatility → Lower rank

What you can do with this information

  • Returns may not adequately compensate for volatility taken
  • Consider smaller allocation given below-average risk-adjusted profile
  • Explore higher-ranked investments with better consistency
  • Assess whether the volatility profile aligns with your portfolio goals

SHSAX Sharpe Ratio Market Positioning

The chart shows SHSAX's Sharpe Ratio relative to all mutual funds on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.


  • Red zone (bottom 25%): 1.30 or lower
  • Yellow zone (middle 50%): 1.30 to 2.32
  • Green zone (top 25%): 2.32 or higher
  • Top 1%: 4.28+
  • Median: 1.93 — half of all investments score higher

How it compares to other similar mutual funds

The table compares BlackRock Health Sciences Opportunities Portfolio's Sharpe Ratio with other mutual funds in the Health & Biotech Equities category across multiple time periods, showing how SHSAX's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 24, 2026.


SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
FBDIXFranklin Biotechnology Discovery Fund3.25
FIJYXFidelity Advisor Biotechnology Fund Class Z2.80
FBTIXFidelity Advisor Biotechnology Fund I Class2.79
FBTAXFidelity Advisor Biotechnology Fund Class A2.77
FBTTXFidelity Advisor Biotechnology Fund Class M2.75
FBIOXFidelity Select Biotechnology Portfolio2.74
FBTCXFidelity Advisor Biotechnology Fund Class C2.72
LYFIXAlphaCentric LifeSci Healthcare Fund2.50
RYOIXRydex Biotechnology Fund2.47
ETIHXEventide Healthcare & Life Sciences Fund2.45
SHSAXBlackRock Health Sciences Opportunities Portfolio1.27

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows SHSAX's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when SHSAX consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.


Loading charts...

Sharpe Ratio Calculator

How does SHSAX fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio